Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with
foscarnet plus ganciclovir.
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or
foscarnet.
Identification of crystals in kidneys of AIDS patients treated with
foscarnet.
Se localizo una mutacion UL97, del CMV, especifica de resistencia a ganciclovir, en la muestra de tejido gastrico, por lo que se decide sustituir el gancicovir por a
foscarnet.
Background:
Foscarnet has been used for the treatment of cytomegalo virus (CMV) disease in HIV/AIDS and in peripheral stem cell transplant (PBSCT) patients with CMV disease.
Consider
foscarnet therapy in patients with laboratory-documented resistant HSV.
Currently, 3 drugs have been approved for the treatment of this condition: ganciclovir,
foscarnet, and cidofovir.
The antiviral drugs
foscarnet and ganciclovir have been approved for treating people with AIDS-associated CMV retinitis.
The HIV-related medicines included AZT (Zidovudine), Zovirax (Acyclovir), Ganciclovir (DHPG), Amphotericin B, Dextran Sulfate, IVIG (Intravenous Gamma Globulin), Nebupent (Aerosol Pentamidine), Pentam (Pentamidine, IM, IV), Bactrim, Septra, Sulfadiazine, Pyrimethanine, Nystatin, Ampicillin, Amoxicillin, Isoniazid (INH), Fluconazole (Diflucan),
Foscarnet, Ketoconazole (Nizoril), Rifampin (Rifadin), and Ciprofloxacin (Cipro).
For example, HIV-infected patients now receive bactrim or pentamidine for the treatment and prevention of Pneumocystis carinii pneumonia and ganciclovir and
foscarnet to treat cytomegalovirus and herpes infections.
Two federally approved drugs, ganciclovir and
foscarnet, fight CMV infection in people with AIDS.
Nonantiretrovirals requiring dose adjustment with declining kidney function * * Acyclovir * Adefovir * Amphotericin B * Cidofovir * Ciprofloxacin * Clarithromycin * Ethambutol * Famciclovir * Fluconazole * Flucytosine *
Foscarnet * Ganciclovir * Isoniazid * Levofloxacin * Pentamidine * Pyrazinamide * Peginterferon alfa-2a * Peginterferon alfa-2b * Ribavirin * Rifabutin * Rifampin * Sulfadiazine * Trimethoprim/sulfamethoxazole * Valacyclovir * Valganciclovir * Source: HIVMA/IDSA CKD guidelines.
